1. Home
  2. SAVA vs ACR Comparison

SAVA vs ACR Comparison

Compare SAVA & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$1.98

Market Cap

156.5M

Sector

Health Care

ML Signal

HOLD

ACR

ACRES Commercial Realty Corp.

HOLD

Current Price

$21.32

Market Cap

169.2M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAVA
ACR
Founded
1998
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
156.5M
169.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SAVA
ACR
Price
$1.98
$21.32
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$5.00
$24.50
AVG Volume (30 Days)
1.0M
49.4K
Earning Date
11-12-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.65
EPS
N/A
0.95
Revenue
N/A
$88,952,000.00
Revenue This Year
N/A
$4.05
Revenue Next Year
N/A
$0.38
P/E Ratio
N/A
$22.33
Revenue Growth
N/A
14.87
52 Week Low
$1.15
$15.64
52 Week High
$4.98
$24.61

Technical Indicators

Market Signals
Indicator
SAVA
ACR
Relative Strength Index (RSI) 30.54 37.42
Support Level $2.15 $23.48
Resistance Level $3.32 $23.97
Average True Range (ATR) 0.18 0.77
MACD -0.08 -0.35
Stochastic Oscillator 1.10 9.21

Price Performance

Historical Comparison
SAVA
ACR

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

Share on Social Networks: